Pharmacovigilance (PV) Outsourcing Market Report

China Pharmacovigilance (PV) Outsourcing Market Professional Research Report 2022-2027, Segmented by Players, Types, End-Users in Major Regions

  • POSTDATE：Aug 23, 2022
  • PAGES：196
  • REPORT CODE：GMM1122000
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • This report offers an overview of the market trends, drivers, and barriers with respect to the China Pharmacovigilance (PV) Outsourcing market. It also provides a detailed overview of the market of different regions across North China, Central China, South China, East China, Northeast China, Southwest China, Northwest China. The report deep analyzes type and application in China Pharmacovigilance (PV) Outsourcing market. Detailed analysis of key players, along with key growth strategies adopted by Pharmacovigilance (PV) Outsourcing industry, the PEST and SWOT analysis are also included. In short, the report will provide a comprehensive view of the industry's development and features.

    By Player:

    • PrimeVigilance

    • IQVIA

    • Novartis

    • iGATE Corporation

    • Pure Drug Safety

    • Covance

    • Symogen

    • Parexel

    • Sciformix

    • C3i Solutions

    • Deloitte Touche Tohmatsu Limited

    • Medpace Holdings

    • PharmInvent

    • SIRO Clinpharm

    • Oracle Corporation

    • Clintec

    • Accenture

    • Ergomed

    • iMED Global Corporation

    • ELC Group

    • MarksMan Healthcare

    By Type:

    • Contract Research Organizations (CROs)

    • Business Process Outsourcing (BPOs)

    By End-User:

    • Premarketing Clinical Trial

    • Post-marketing Clinical Practice

    • Other

    By Region:

    • North China

    • Central China

    • South China

    • East China

    • Northeast China

    • Southwest China

    • Northwest China

  • TABLE OF CONTENT

    1 Report Overview

    • 1.1 Product Definition and Scope

    • 1.2 PEST (Political, Economic, Social and Technological) Analysis of Pharmacovigilance (PV) Outsourcing Market

    • 1.3 Market Segment by Type

    • 1.3.1 China Pharmacovigilance (PV) Outsourcing Market Size and Growth Rate of Contract Research Organizations (CROs) from 2016 to 2027

    • 1.3.2 China Pharmacovigilance (PV) Outsourcing Market Size and Growth Rate of Business Process Outsourcing (BPOs) from 2016 to 2027

    • 1.4 Market Segment by Application

    • 1.4.1 China Pharmacovigilance (PV) Outsourcing Market Size and Growth Rate of Premarketing Clinical Trial from 2016 to 2027

    • 1.4.2 China Pharmacovigilance (PV) Outsourcing Market Size and Growth Rate of Post-marketing Clinical Practice from 2016 to 2027

    • 1.4.3 China Pharmacovigilance (PV) Outsourcing Market Size and Growth Rate of Other from 2016 to 2027

    • 1.5 Market Segment by Regions

      • 1.5.1 North China Pharmacovigilance (PV) Outsourcing Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.2 Central China Pharmacovigilance (PV) Outsourcing Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.3 South China Pharmacovigilance (PV) Outsourcing Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.4 East China Pharmacovigilance (PV) Outsourcing Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.5 Northeast China Pharmacovigilance (PV) Outsourcing Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.6 Southwest China Pharmacovigilance (PV) Outsourcing Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.7 Northwest China Pharmacovigilance (PV) Outsourcing Consumption Market Size and Growth Rate from 2016 to 2027

    2 Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Market Challenges and Restraints

      • 2.1.2 Market Opportunities and Potentials

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape Analysis

      • 2.2.1 Industrial Concentration Analysis

      • 2.2.2 Porter's Five Forces Analysis of the Industry

      • 2.2.3 SWOT Analysis for New Entrants

    • 2.3 Coronavirus (COVID-19) Distribution and its Impact on the Industry

    3 Segmentation of Pharmacovigilance (PV) Outsourcing Market by Types

    • 3.1 Products Development Trends of Different Types

    • 3.2 Commercial Products Types of Major Vendors

    • 3.3 Competitive Landscape Analysis of Different Types

    • 3.4 Market Size of Pharmacovigilance (PV) Outsourcing by Major Types

    • 3.4.1 Market Size and Growth Rate of Contract Research Organizations (CROs)

    • 3.4.2 Market Size and Growth Rate of Business Process Outsourcing (BPOs)

    4 Segmentation of Pharmacovigilance (PV) Outsourcing Market by End-Users

    • 4.1 Downstream Client Analysis by End-Users

    • 4.2 Competitive Landscape Analysis of Different End-Users

    • 4.3 Market Potential Analysis of Different End-Users

    • 4.4 Market Size of Pharmacovigilance (PV) Outsourcing by Major End-Users

    • 4.4.1 Market Size and Growth Rate of Pharmacovigilance (PV) Outsourcing in Premarketing Clinical Trial

    • 4.4.2 Market Size and Growth Rate of Pharmacovigilance (PV) Outsourcing in Post-marketing Clinical Practice

    • 4.4.3 Market Size and Growth Rate of Pharmacovigilance (PV) Outsourcing in Other

    5 Market Analysis by Regions

    • 5.1 China Pharmacovigilance (PV) Outsourcing Production Analysis by Regions

    • 5.2 China Pharmacovigilance (PV) Outsourcing Consumption Analysis by Regions

    • 5.3 Coronavirus (COVID-19) Impact on China Economy

    6 North China Pharmacovigilance (PV) Outsourcing Landscape Analysis

    • 6.1 North China Pharmacovigilance (PV) Outsourcing Landscape Analysis by Major Types

    • 6.2 North China Pharmacovigilance (PV) Outsourcing Landscape Analysis by Major End-Users

    7 Central China Pharmacovigilance (PV) Outsourcing Landscape Analysis

    • 7.1 Central China Pharmacovigilance (PV) Outsourcing Landscape Analysis by Major Types

    • 7.2 Central China Pharmacovigilance (PV) Outsourcing Landscape Analysis by Major End-Users

    8 South China Pharmacovigilance (PV) Outsourcing Landscape Analysis

    • 8.1 South China Pharmacovigilance (PV) Outsourcing Landscape Analysis by Major Types

    • 8.2 South China Pharmacovigilance (PV) Outsourcing Landscape Analysis by Major End-Users

    9 East China Pharmacovigilance (PV) Outsourcing Landscape Analysis

    • 9.1 East China Pharmacovigilance (PV) Outsourcing Landscape Analysis by Major Types

    • 9.2 East China Pharmacovigilance (PV) Outsourcing Landscape Analysis by Major End-Users

    10 Northeast China Pharmacovigilance (PV) Outsourcing Landscape Analysis

    • 10.1 Northeast China Pharmacovigilance (PV) Outsourcing Landscape Analysis by Major Types

    • 10.2 Northeast China Pharmacovigilance (PV) Outsourcing Landscape Analysis by Major End-Users

    11 Southwest China Pharmacovigilance (PV) Outsourcing Landscape Analysis

    • 11.1 Southwest China Pharmacovigilance (PV) Outsourcing Landscape Analysis by Major Types

    • 11.2 Southwest China Pharmacovigilance (PV) Outsourcing Landscape Analysis by Major End-Users

    12 Northwest China Pharmacovigilance (PV) Outsourcing Landscape Analysis

    • 12.1 Northwest China Pharmacovigilance (PV) Outsourcing Landscape Analysis by Major Types

    • 12.2 Northwest China Pharmacovigilance (PV) Outsourcing Landscape Analysis by Major End-Users

    13 Major Players Profiles

    • 13.1 PrimeVigilance

      • 13.1.1 PrimeVigilance Company Profile and Recent Development

      • 13.1.2 Market Performance

      • 13.1.3 Product and Service Introduction

    • 13.2 IQVIA

      • 13.2.1 IQVIA Company Profile and Recent Development

      • 13.2.2 Market Performance

      • 13.2.3 Product and Service Introduction

    • 13.3 Novartis

      • 13.3.1 Novartis Company Profile and Recent Development

      • 13.3.2 Market Performance

      • 13.3.3 Product and Service Introduction

    • 13.4 iGATE Corporation

      • 13.4.1 iGATE Corporation Company Profile and Recent Development

      • 13.4.2 Market Performance

      • 13.4.3 Product and Service Introduction

    • 13.5 Pure Drug Safety

      • 13.5.1 Pure Drug Safety Company Profile and Recent Development

      • 13.5.2 Market Performance

      • 13.5.3 Product and Service Introduction

    • 13.6 Covance

      • 13.6.1 Covance Company Profile and Recent Development

      • 13.6.2 Market Performance

      • 13.6.3 Product and Service Introduction

    • 13.7 Symogen

      • 13.7.1 Symogen Company Profile and Recent Development

      • 13.7.2 Market Performance

      • 13.7.3 Product and Service Introduction

    • 13.8 Parexel

      • 13.8.1 Parexel Company Profile and Recent Development

      • 13.8.2 Market Performance

      • 13.8.3 Product and Service Introduction

    • 13.9 Sciformix

      • 13.9.1 Sciformix Company Profile and Recent Development

      • 13.9.2 Market Performance

      • 13.9.3 Product and Service Introduction

    • 13.10 C3i Solutions

      • 13.10.1 C3i Solutions Company Profile and Recent Development

      • 13.10.2 Market Performance

      • 13.10.3 Product and Service Introduction

    • 13.11 Deloitte Touche Tohmatsu Limited

      • 13.11.1 Deloitte Touche Tohmatsu Limited Company Profile and Recent Development

      • 13.11.2 Market Performance

      • 13.11.3 Product and Service Introduction

    • 13.12 Medpace Holdings

      • 13.12.1 Medpace Holdings Company Profile and Recent Development

      • 13.12.2 Market Performance

      • 13.12.3 Product and Service Introduction

    • 13.13 PharmInvent

      • 13.13.1 PharmInvent Company Profile and Recent Development

      • 13.13.2 Market Performance

      • 13.13.3 Product and Service Introduction

    • 13.14 SIRO Clinpharm

      • 13.14.1 SIRO Clinpharm Company Profile and Recent Development

      • 13.14.2 Market Performance

      • 13.14.3 Product and Service Introduction

    • 13.15 Oracle Corporation

      • 13.15.1 Oracle Corporation Company Profile and Recent Development

      • 13.15.2 Market Performance

      • 13.15.3 Product and Service Introduction

    • 13.16 Clintec

      • 13.16.1 Clintec Company Profile and Recent Development

      • 13.16.2 Market Performance

      • 13.16.3 Product and Service Introduction

    • 13.17 Accenture

      • 13.17.1 Accenture Company Profile and Recent Development

      • 13.17.2 Market Performance

      • 13.17.3 Product and Service Introduction

    • 13.18 Ergomed

      • 13.18.1 Ergomed Company Profile and Recent Development

      • 13.18.2 Market Performance

      • 13.18.3 Product and Service Introduction

    • 13.19 iMED Global Corporation

      • 13.19.1 iMED Global Corporation Company Profile and Recent Development

      • 13.19.2 Market Performance

      • 13.19.3 Product and Service Introduction

    • 13.20 ELC Group

      • 13.20.1 ELC Group Company Profile and Recent Development

      • 13.20.2 Market Performance

      • 13.20.3 Product and Service Introduction

    • 13.21 MarksMan Healthcare

      • 13.21.1 MarksMan Healthcare Company Profile and Recent Development

      • 13.21.2 Market Performance

      • 13.21.3 Product and Service Introduction

    The List of Tables and Figures

    • Figure Product Picture

    • Figure China Pharmacovigilance (PV) Outsourcing Market Size and Growth Rate of Contract Research Organizations (CROs) from 2016 to 2027

    • Figure China Pharmacovigilance (PV) Outsourcing Market Size and Growth Rate of Business Process Outsourcing (BPOs) from 2016 to 2027

    • Figure Market Share by Type in 2016

    • Figure Market Share by Type in 2021

    • Figure Market Share by Type in 2027

    • Figure China Pharmacovigilance (PV) Outsourcing Market Size and Growth Rate of Premarketing Clinical Trial from 2016 to 2027

    • Figure China Pharmacovigilance (PV) Outsourcing Market Size and Growth Rate of Post-marketing Clinical Practice from 2016 to 2027

    • Figure China Pharmacovigilance (PV) Outsourcing Market Size and Growth Rate of Other from 2016 to 2027

    • Figure Market Share by End-User in 2016

    • Figure Market Share by End-User in 2021

    • Figure Market Share by End-User in 2027

    • Figure North China Pharmacovigilance (PV) Outsourcing Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Central China Pharmacovigilance (PV) Outsourcing Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure South China Pharmacovigilance (PV) Outsourcing Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure East China Pharmacovigilance (PV) Outsourcing Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Northeast China Pharmacovigilance (PV) Outsourcing Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Southwest China Pharmacovigilance (PV) Outsourcing Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Northwest China Pharmacovigilance (PV) Outsourcing Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Development Trends and Industry Dynamics of Pharmacovigilance (PV) Outsourcing Industry

    • Figure Market Challenges and Restraints

    • Figure Market Opportunities and Potentials

    • Table Mergers and Acquisition

    • Figure Market Share of TOP 3 Players in 2020

    • Figure Market Share of TOP 5 Players in 2021

    • Figure Market Share of TOP 6 Players from 2016 to 2021

    • Figure Porter's Five Forces Analysis

    • Figure New Entrant SWOT Analysis

    • Figure Coronavirus (COVID-19) Map of China

    • Table Coronavirus (COVID-19) Impact on the Industry

    • Figure Specifications of Different Types of Pharmacovigilance (PV) Outsourcing

    • Figure Development Trends of Different Types

    • Table Commercial Products Types of Major Vendors

    • Figure Competitive Landscape Analysis of Different Types

    • Table Consumption of Pharmacovigilance (PV) Outsourcing by Different Types from 2016 to 2027

    • Table Consumption Share of Pharmacovigilance (PV) Outsourcing by Different Types from 2016 to 2027

    • Figure Market Size and Growth Rate of Contract Research Organizations (CROs)

    • Figure Market Size and Growth Rate of Business Process Outsourcing (BPOs)

    • Table Downstream Client Analysis by End-Users

    • Figure Competitive Landscape Analysis of Different End-Users

    • Table Market Potential Analysis of Different End-Users

    • Figure Consumption of Pharmacovigilance (PV) Outsourcing by Different End-Users from 2016 to 2027

    • Table Consumption Share of Pharmacovigilance (PV) Outsourcing by Different End-Users from 2016 to 2027

    • Figure Market Size and Growth Rate of Premarketing Clinical Trial

    • Figure Market Size and Growth Rate of Post-marketing Clinical Practice

    • Figure Market Size and Growth Rate of Other

    • Table China Pharmacovigilance (PV) Outsourcing Production by Regions

    • Table China Pharmacovigilance (PV) Outsourcing Production Share by Regions

    • Figure China Pharmacovigilance (PV) Outsourcing Production Share by Regions in 2016

    • Figure China Pharmacovigilance (PV) Outsourcing Production Share by Regions in 2021

    • Figure China Pharmacovigilance (PV) Outsourcing Production Share by Regions in 2027

    • Table China Pharmacovigilance (PV) Outsourcing Consumption by Regions

    • Table China Pharmacovigilance (PV) Outsourcing Consumption Share by Regions

    • Figure China Pharmacovigilance (PV) Outsourcing Consumption Share by Regions in 2016

    • Figure China Pharmacovigilance (PV) Outsourcing Consumption Share by Regions in 2021

    • Figure China Pharmacovigilance (PV) Outsourcing Consumption Share by Regions in 2027

    • Table North China Pharmacovigilance (PV) Outsourcing Consumption by Types from 2016 to 2027

    • Table North China Pharmacovigilance (PV) Outsourcing Consumption Share by Types from 2016 to 2027

    • Figure North China Pharmacovigilance (PV) Outsourcing Consumption Share by Types in 2016

    • Figure North China Pharmacovigilance (PV) Outsourcing Consumption Share by Types in 2021

    • Figure North China Pharmacovigilance (PV) Outsourcing Consumption Share by Types in 2027

    • Table North China Pharmacovigilance (PV) Outsourcing Consumption by End-Users from 2016 to 2027

    • Table North China Pharmacovigilance (PV) Outsourcing Consumption Share by End-Users from 2016 to 2027

    • Figure North China Pharmacovigilance (PV) Outsourcing Consumption Share by End-Users in 2016

    • Figure North China Pharmacovigilance (PV) Outsourcing Consumption Share by End-Users in 2021

    • Figure North China Pharmacovigilance (PV) Outsourcing Consumption Share by End-Users in 2027

    • Table Central China Pharmacovigilance (PV) Outsourcing Consumption by Types from 2016 to 2027

    • Table Central China Pharmacovigilance (PV) Outsourcing Consumption Share by Types from 2016 to 2027

    • Figure Central China Pharmacovigilance (PV) Outsourcing Consumption Share by Types in 2016

    • Figure Central China Pharmacovigilance (PV) Outsourcing Consumption Share by Types in 2021

    • Figure Central China Pharmacovigilance (PV) Outsourcing Consumption Share by Types in 2027

    • Table Central China Pharmacovigilance (PV) Outsourcing Consumption by End-Users from 2016 to 2027

    • Table Central China Pharmacovigilance (PV) Outsourcing Consumption Share by End-Users from 2016 to 2027

    • Figure Central China Pharmacovigilance (PV) Outsourcing Consumption Share by End-Users in 2016

    • Figure Central China Pharmacovigilance (PV) Outsourcing Consumption Share by End-Users in 2021

    • Figure Central China Pharmacovigilance (PV) Outsourcing Consumption Share by End-Users in 2027

    • Table South China Pharmacovigilance (PV) Outsourcing Consumption by Types from 2016 to 2027

    • Table South China Pharmacovigilance (PV) Outsourcing Consumption Share by Types from 2016 to 2027

    • Figure South China Pharmacovigilance (PV) Outsourcing Consumption Share by Types in 2016

    • Figure South China Pharmacovigilance (PV) Outsourcing Consumption Share by Types in 2021

    • Figure South China Pharmacovigilance (PV) Outsourcing Consumption Share by Types in 2027

    • Table South China Pharmacovigilance (PV) Outsourcing Consumption by End-Users from 2016 to 2027

    • Table South China Pharmacovigilance (PV) Outsourcing Consumption Share by End-Users from 2016 to 2027

    • Figure South China Pharmacovigilance (PV) Outsourcing Consumption Share by End-Users in 2016

    • Figure South China Pharmacovigilance (PV) Outsourcing Consumption Share by End-Users in 2021

    • Figure South China Pharmacovigilance (PV) Outsourcing Consumption Share by End-Users in 2027

    • Table East China Pharmacovigilance (PV) Outsourcing Consumption by Types from 2016 to 2027

    • Table East China Pharmacovigilance (PV) Outsourcing Consumption Share by Types from 2016 to 2027

    • Figure East China Pharmacovigilance (PV) Outsourcing Consumption Share by Types in 2016

    • Figure East China Pharmacovigilance (PV) Outsourcing Consumption Share by Types in 2021

    • Figure East China Pharmacovigilance (PV) Outsourcing Consumption Share by Types in 2027

    • Table East China Pharmacovigilance (PV) Outsourcing Consumption by End-Users from 2016 to 2027

    • Table East China Pharmacovigilance (PV) Outsourcing Consumption Share by End-Users from 2016 to 2027

    • Figure East China Pharmacovigilance (PV) Outsourcing Consumption Share by End-Users in 2016

    • Figure East China Pharmacovigilance (PV) Outsourcing Consumption Share by End-Users in 2021

    • Figure East China Pharmacovigilance (PV) Outsourcing Consumption Share by End-Users in 2027

    • Table Northeast China Pharmacovigilance (PV) Outsourcing Consumption by Types from 2016 to 2027

    • Table Northeast China Pharmacovigilance (PV) Outsourcing Consumption Share by Types from 2016 to 2027

    • Figure Northeast China Pharmacovigilance (PV) Outsourcing Consumption Share by Types in 2016

    • Figure Northeast China Pharmacovigilance (PV) Outsourcing Consumption Share by Types in 2021

    • Figure Northeast China Pharmacovigilance (PV) Outsourcing Consumption Share by Types in 2027

    • Table Northeast China Pharmacovigilance (PV) Outsourcing Consumption by End-Users from 2016 to 2027

    • Table Northeast China Pharmacovigilance (PV) Outsourcing Consumption Share by End-Users from 2016 to 2027

    • Figure Northeast China Pharmacovigilance (PV) Outsourcing Consumption Share by End-Users in 2016

    • Figure Northeast China Pharmacovigilance (PV) Outsourcing Consumption Share by End-Users in 2021

    • Figure Northeast China Pharmacovigilance (PV) Outsourcing Consumption Share by End-Users in 2027

    • Table Southwest China Pharmacovigilance (PV) Outsourcing Consumption by Types from 2016 to 2027

    • Table Southwest China Pharmacovigilance (PV) Outsourcing Consumption Share by Types from 2016 to 2027

    • Figure Southwest China Pharmacovigilance (PV) Outsourcing Consumption Share by Types in 2016

    • Figure Southwest China Pharmacovigilance (PV) Outsourcing Consumption Share by Types in 2021

    • Figure Southwest China Pharmacovigilance (PV) Outsourcing Consumption Share by Types in 2027

    • Table Southwest China Pharmacovigilance (PV) Outsourcing Consumption by End-Users from 2016 to 2027

    • Table Southwest China Pharmacovigilance (PV) Outsourcing Consumption Share by End-Users from 2016 to 2027

    • Figure Southwest China Pharmacovigilance (PV) Outsourcing Consumption Share by End-Users in 2016

    • Figure Southwest China Pharmacovigilance (PV) Outsourcing Consumption Share by End-Users in 2021

    • Figure Southwest China Pharmacovigilance (PV) Outsourcing Consumption Share by End-Users in 2027

    • Table Northwest China Pharmacovigilance (PV) Outsourcing Consumption by Types from 2016 to 2027

    • Table Northwest China Pharmacovigilance (PV) Outsourcing Consumption Share by Types from 2016 to 2027

    • Figure Northwest China Pharmacovigilance (PV) Outsourcing Consumption Share by Types in 2016

    • Figure Northwest China Pharmacovigilance (PV) Outsourcing Consumption Share by Types in 2021

    • Figure Northwest China Pharmacovigilance (PV) Outsourcing Consumption Share by Types in 2027

    • Table Northwest China Pharmacovigilance (PV) Outsourcing Consumption by End-Users from 2016 to 2027

    • Table Northwest China Pharmacovigilance (PV) Outsourcing Consumption Share by End-Users from 2016 to 2027

    • Figure Northwest China Pharmacovigilance (PV) Outsourcing Consumption Share by End-Users in 2016

    • Figure Northwest China Pharmacovigilance (PV) Outsourcing Consumption Share by End-Users in 2021

    • Figure Northwest China Pharmacovigilance (PV) Outsourcing Consumption Share by End-Users in 2027

    • Table Company Profile and Development Status of PrimeVigilance

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of PrimeVigilance

    • Figure Sales and Growth Rate Analysis of PrimeVigilance

    • Figure Revenue and Market Share Analysis of PrimeVigilance

    • Table Product and Service Introduction of PrimeVigilance

    • Table Company Profile and Development Status of IQVIA

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of IQVIA

    • Figure Sales and Growth Rate Analysis of IQVIA

    • Figure Revenue and Market Share Analysis of IQVIA

    • Table Product and Service Introduction of IQVIA

    • Table Company Profile and Development Status of Novartis

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Novartis

    • Figure Sales and Growth Rate Analysis of Novartis

    • Figure Revenue and Market Share Analysis of Novartis

    • Table Product and Service Introduction of Novartis

    • Table Company Profile and Development Status of iGATE Corporation

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of iGATE Corporation

    • Figure Sales and Growth Rate Analysis of iGATE Corporation

    • Figure Revenue and Market Share Analysis of iGATE Corporation

    • Table Product and Service Introduction of iGATE Corporation

    • Table Company Profile and Development Status of Pure Drug Safety

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Pure Drug Safety

    • Figure Sales and Growth Rate Analysis of Pure Drug Safety

    • Figure Revenue and Market Share Analysis of Pure Drug Safety

    • Table Product and Service Introduction of Pure Drug Safety

    • Table Company Profile and Development Status of Covance

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Covance

    • Figure Sales and Growth Rate Analysis of Covance

    • Figure Revenue and Market Share Analysis of Covance

    • Table Product and Service Introduction of Covance

    • Table Company Profile and Development Status of Symogen

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Symogen

    • Figure Sales and Growth Rate Analysis of Symogen

    • Figure Revenue and Market Share Analysis of Symogen

    • Table Product and Service Introduction of Symogen

    • Table Company Profile and Development Status of Parexel

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Parexel

    • Figure Sales and Growth Rate Analysis of Parexel

    • Figure Revenue and Market Share Analysis of Parexel

    • Table Product and Service Introduction of Parexel

    • Table Company Profile and Development Status of Sciformix

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Sciformix

    • Figure Sales and Growth Rate Analysis of Sciformix

    • Figure Revenue and Market Share Analysis of Sciformix

    • Table Product and Service Introduction of Sciformix

    • Table Company Profile and Development Status of C3i Solutions

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of C3i Solutions

    • Figure Sales and Growth Rate Analysis of C3i Solutions

    • Figure Revenue and Market Share Analysis of C3i Solutions

    • Table Product and Service Introduction of C3i Solutions

    • Table Company Profile and Development Status of Deloitte Touche Tohmatsu Limited

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Deloitte Touche Tohmatsu Limited

    • Figure Sales and Growth Rate Analysis of Deloitte Touche Tohmatsu Limited

    • Figure Revenue and Market Share Analysis of Deloitte Touche Tohmatsu Limited

    • Table Product and Service Introduction of Deloitte Touche Tohmatsu Limited

    • Table Company Profile and Development Status of Medpace Holdings

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Medpace Holdings

    • Figure Sales and Growth Rate Analysis of Medpace Holdings

    • Figure Revenue and Market Share Analysis of Medpace Holdings

    • Table Product and Service Introduction of Medpace Holdings

    • Table Company Profile and Development Status of PharmInvent

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of PharmInvent

    • Figure Sales and Growth Rate Analysis of PharmInvent

    • Figure Revenue and Market Share Analysis of PharmInvent

    • Table Product and Service Introduction of PharmInvent

    • Table Company Profile and Development Status of SIRO Clinpharm

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of SIRO Clinpharm

    • Figure Sales and Growth Rate Analysis of SIRO Clinpharm

    • Figure Revenue and Market Share Analysis of SIRO Clinpharm

    • Table Product and Service Introduction of SIRO Clinpharm

    • Table Company Profile and Development Status of Oracle Corporation

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Oracle Corporation

    • Figure Sales and Growth Rate Analysis of Oracle Corporation

    • Figure Revenue and Market Share Analysis of Oracle Corporation

    • Table Product and Service Introduction of Oracle Corporation

    • Table Company Profile and Development Status of Clintec

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Clintec

    • Figure Sales and Growth Rate Analysis of Clintec

    • Figure Revenue and Market Share Analysis of Clintec

    • Table Product and Service Introduction of Clintec

    • Table Company Profile and Development Status of Accenture

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Accenture

    • Figure Sales and Growth Rate Analysis of Accenture

    • Figure Revenue and Market Share Analysis of Accenture

    • Table Product and Service Introduction of Accenture

    • Table Company Profile and Development Status of Ergomed

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Ergomed

    • Figure Sales and Growth Rate Analysis of Ergomed

    • Figure Revenue and Market Share Analysis of Ergomed

    • Table Product and Service Introduction of Ergomed

    • Table Company Profile and Development Status of iMED Global Corporation

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of iMED Global Corporation

    • Figure Sales and Growth Rate Analysis of iMED Global Corporation

    • Figure Revenue and Market Share Analysis of iMED Global Corporation

    • Table Product and Service Introduction of iMED Global Corporation

    • Table Company Profile and Development Status of ELC Group

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of ELC Group

    • Figure Sales and Growth Rate Analysis of ELC Group

    • Figure Revenue and Market Share Analysis of ELC Group

    • Table Product and Service Introduction of ELC Group

    • Table Company Profile and Development Status of MarksMan Healthcare

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of MarksMan Healthcare

    • Figure Sales and Growth Rate Analysis of MarksMan Healthcare

    • Figure Revenue and Market Share Analysis of MarksMan Healthcare

    • Table Product and Service Introduction of MarksMan Healthcare


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US